Top compounds associated with response to ATG2A


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.007
mRNA Bicalutamide GDSC1000 pan-cancer AAC 0.091 0.008
mRNA Cetuximab GDSC1000 pan-cancer AAC 0.088 0.008
mRNA piperlongumine:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.008
mRNA prima-1 CTRPv2 pan-cancer AAC 0.084 0.008
mRNA CD-1530 CTRPv2 pan-cancer AAC -0.1 0.008
mRNA AM-580 CTRPv2 pan-cancer AAC -0.098 0.009
mRNA MLN4924 CTRPv2 pan-cancer AAC -0.089 0.01
mRNA lapatinib gCSI pan-cancer AAC 0.14 0.01
mRNA BMS-270394 CTRPv2 pan-cancer AAC -0.096 0.01
Download CSV